Brief: Palisade Bio Reports Year End 2022 Financial Results And Provides Corporate Update
23/03/2023 13:11
March 23 (Reuters) - Palisade Bio Inc PALI.O :
* PALISADE BIO REPORTS YEAR END 2022 FINANCIAL RESULTS AND
PROVIDES CORPORATE UPDATE
* PALISADE BIO INC - STRONG BALANCE SHEET WITH SUFFICIENT
CASH
EXPECTED TO FUND OPERATIONS INTO MID-2024
* PALISADE BIO INC - PHASE 2 TOPLINE DATA READOUT FOR
PREVENTION
OF POST-SURGICAL ABDOMINAL ADHESIONS ON TRACK FOR Q2 2023
Source text for Eikon: ID:nGNX3G4nhw
Further company coverage: PALI.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Palisade Bio
See all newsPalisade Bio Inc reports results for the quarter ended June 30 - Earnings Summary
Palisade Bio Q2 net loss widens on higher R&D costs
Brief: Palisade Bio Q2 EPS USD -0.05
Palisade Bio Inc expected to post a loss of 5 cents a share - Earnings Preview
Brief: Palisade Bio Inc - May Offer And Sell Up To $300 Million Of Securities - SEC Filing